Results for tag: "Stem Cell Partnering"

The Stem Cell Partnering market is a subset of the larger stem cell industry, which focuses on the development of stem cell-based therapies and products. It involves the collaboration of companies, universities, and research institutions to develop and commercialize stem cell-based products. This market is driven by the increasing demand for stem cell-based therapies and products, as well as the need for new treatments for various diseases. The Stem Cell Partnering market is composed of a variety of stakeholders, including biotechnology companies, pharmaceutical companies, academic institutions, and venture capitalists. These stakeholders collaborate to develop and commercialize stem cell-based products, such as cell therapies, tissue engineering, and regenerative medicine. Some of the companies in the Stem Cell Partnering market include Celgene Corporation, Novartis, Pfizer, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals. Other companies include Athersys, Inc., BioTime, Inc., and Osiris Therapeutics, Inc. Show Less Read more